Thermosensitive nanofibers loaded with ciprofloxacin as antibacterial wound dressing materials by Li, H et al.
1Thermosensitive nanofibers loaded with ciprofloxacin as
antibacterial wound dressing materials
Heyu Li1, Gareth R. Williams2, Junzi Wu1, Yao Lv1, Xiaozhu Sun1, Huanling Wu1,
Li-Min Zhu1*5
1. College of Chemistry, Chemical Engineering and Biotechnology, Donghua
University，Shanghai, 201620, China
2. UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK
Corresponding author E-mail: lzhu@dhu.edu.cn Tel：00862167792655
Abstract10
To obtain wound dressings which could be removed easily without secondary injuries,
we prepared thermoresponsive electrospun fiber mats containing poly(di(ethylene
glycol) methyl ether methacrylate (PDEGMA). Blend fibers of PDEGMA and
(poly(l-lactic acid-co-ɛ-caprolactone) (P(LLA-CL) were fabricated via electrospinning, 
and analogous fibers containing the antibiotic ciprofloxacin (CIF) were also prepared.15
Smooth cylindrical fibers were obtained, albeit with a small amount of beading visible
for the ciprofloxacin-loaded fibers. X-ray diffraction showed the drug to exist in the
amorphous physical form post-electrospinning. The composite fibers showed distinct
thermosensitive properties and gave sustained release of CIF over more than 160
hours in vitro. The fibers could promote the proliferation of fibroblasts, and by20
varying the temperature cells could easily be attached to and detached from the fibers.
Antibacterial tests demonstrated that fibers loaded with ciprofloxacin were effective
in inhibiting the growth of E. coli and S. aureus. In vivo investigations on rats
indicated that the composite PDEGMA/P(LLA-CL) fibers loaded with CIF had much
more potent wound healing properties than a commercial gauze and CIF-loaded fibers25
made solely of P(LLA-CL). These results demonstrate the potential of
PDEGMA/P(LLA-CL)/ ciprofloxacin fibers as advanced wound dressing materials.
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1.Introduction
Wound dressings comprise an important segment of the wound care market (Boateng
et al., 2008). Contemporary dressings are designed to maintain a suitable environment35
for healing: to do this, they must absorb excess exudates; offer thermal insulation,
gaseous and fluid exchanges; and, avoid allergic reactions, toxicity, scarring and
sensitization. They must also be sterile (Zahedi et al., 2010). A range of dressing types
has been explored, including films, foams, hydrogels, hydrocolloids and hydrofibers
(Thomas et al., 1988; Cho et al., 2002; Newman et al., 2006; Thu et al., 2012; Tan et40
al., 2013).
Nanofiber-based dressings made by electrospinning have several clear advantages as
wound dressing materials. In addition to their high surface area-to-volume ratio,
porosity and the great tunability of these systems, they also often resemble the
morphological structure of the extra-cellular matrix (ECM) and have good45
biocompatibility (Charernsriwilaiwat et al., 2012; Pelipenko et al., 2013; Thakur et al.,
2008). It has been found that electrospun wound dressings have good hemostasis,
absorbability, and semi-permeability (Li et al., 2016; Zhang et al., 2005). Multiple
therapeutic compounds can easily be incorporated into nanofibers via this route,
leading to facile production of multifunctional dressings. In the clinic, wound50
dressings need to be replaced periodically, which inevitably causes some secondary
injury as tissue adhered to the dressing is pulled off during replacement. This
compromises the healing process. This is potentially a particular problem with
nanofiber-based dressings because of their biomimetic structures. To solve this
problem, thermosensitive polymers can be employed.55
Thermoresponsive polymers undergo phase transitions in response to temperature
3changes, and have attracted widespread attention (Dimitrov et al., 2007; Behl et al.,
2010). Some researchers have demonstrated that thermosensitive materials can
effectively control cell adhesion and detachment through variation of the temperature
(Schild, 1992). Poly(N-isopropylacrylamide) (PNIPAM), with a lower critical60
solution temperature (LCST) of 32 °C, has been by far the most studied
thermoresponsive polymer (Akiyama et al., 2004; Gil and Hudson, 2007), and
thermosensitive would dressings made from PNIPAM have been reported in the
literature (Yang et al., 2008; Wang et al., 2006; Heilmann et al., 2008; Reddy et al.,
2008). Such systems exhibit a chain-to-globule transition as the temperature is raised65
through the LCST. The strength of interactions between the polymer and cells is
generally much greater above the LCST (Akiyama et al., 2004), and thus if the LCST
is a little below the human body temperature a low-temperature treatment could be
applied to reduce attractions between the polymer and cells. This will promote
detachment of cells from the dressing and thereby can reduce secondary injuries, as70
the dressing is less likely to bring tissue with it upon changing. As a result pain and
secondary injury can be much reduced. There are several reports of thermosensitive
wound dressings in the literature. For example, chitosan containing
polyurethane/PNIPAM polymer membranes have shown good antibacterial ability
against P. aeruginosa and S. aureus. They also could support the growth of75
3T3fibroblasts (Yang et al., 2008). Wang et al. reported that polymer membranes
synthesized from N-isopropylacrylamide, methyl methacrylate, and 2-hydroxyethyl
methacrylate exhibit excellent thermosensitivity and cell attachment/detachment
properties. The highest detachment efficiency with L929 cells was about 90% at
15 °C (Wang et al., 2006). Most of the thermosensitive dressings based on PNIPAM80
were not made by electrospinning and do not have the advantages of nanofibers,
however.
In recent years, different oligo(ethylene glycol) methyl ether methacrylate
(OEGMA)-based polymers have been synthesized and studied as alternatives to
PNIPAM. The former have graft structures composed of a carbon–carbon backbone85
4and multiple oligo(ethylene glycol) side-chains (Lutz, et al., 2008). They have
inherent advantages over PNIPAM, including better bio-repellency below the LCST,
reversible phase transitions without marked hysteresis, and bio-inert properties (Lutz,
2011).
In this work we used di(ethylene glycol) methyl ether methacrylate (DEGMA) to90
synthesize the thermosensitive polymer PDEGMA, which has an LCST just below
30 °C (Han et al., 2003; Becer et al., 2008; Ishizone et al., 2008). To produce
high-quality fibers with regular and homogenous morphologies, PDEGMA was then
electrospun into nanofibers in combination with P(LLA-CL). The latter has been
widely utilized in electrospinning, and found to have high spinnability as well as good95
biocompatibility, biodegradability and mechanical properties (Li et al., 2009). These
are all necessary for wound dressing materials. Ciprofloxacin, a fluoroquinolone
antibiotic, was additionally loaded in the composite nanofibers. In vitro and in vivo
studies of the drug-loaded PDEGMA/ P(LLA-CL) nanofibers were undertaken.
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2.Materials and methods
2.1 Materials
Di(ethylene glycol) methyl ether methacrylate (DEGMA, 95%),
1,1′-azobis(cyclohexanecarbonitrile) (VAZO-88, 98%), ciprofloxacin (CIF, ≥ 98%), 105 
phosphate-buffered saline (PBS), sodium azide, penicillin, trypsin and thiazolyl blue
(MTT) were purchased from Sigma-Aldrich Ltd (USA). Dimethyl formamide (DMF),
dichloromethane, formaldehyde and n-hexane were obtained from the Sinopharm
Chemical Reagent Co., Ltd (China). A copolymer of P(LLA-CL) (50:50; Mw = 34.5
× 104 g/mol) was provided by Nara Medical University (Japan).110
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, 99.5%) was procured from the Aladdin
Industrial Corporation (China). CD34 and collagen type I polyclonal antibodies,
β-actin monoclonal antibody, PVDF touch, and ECL luminescence kits were obtained 
from Santa Cruz (USA), and the corresponding secondary antibodies were purchased
5from the Zhongshan Golden Bridge Company (China). L929 cells were provided by115
the Institute of Biochemistry and Cell Biology (Chinese Academy of Sciences, China).
Dimethyl sulfoxide (DMSO) and DMEM culture medium were sourced from Jinuo
Biological Medicine Technology Ltd. (China). All other chemicals used were
analytical grade, and water was doubly distilled before use.
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2.2 Thermosensitive polymer synthesis and characterization
The PDEGMA polymer was prepared by free-radical polymerization according to the
literature (Sun et al., 2014). Briefly, 3.76 g of DEGMA and 0.005 g of the initiator
VAZO-88 were dissolved in 4 mL of DMF, to give a molar ratio of DEGMA :
VAZO-88 of 2000:1. The reaction mixture was heated at 90 °C under nitrogen for 1.5125
h. The resultant solid was initially dissolved in dichloromethane before PDEGMA
was precipitated through the addition of n-hexane. The dissolution/precipitation
process was repeated three times and then the product dried for 3 days in a vacuum
oven (DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd., China). Successful
polymerization was verified by 1H nuclear magnetic resonance (AV-400 instrument,130
Bruker, Germany). Molecular weights (Mw and Mn) and molecular weight
distributions were determined by gel permeation chromatography (GPC)
measurements on a Waters LS measurement system (Waters, USA) with
tetrahydrofuran (THF) as the solvent. The flow rate was 1.0 mL/min, and the column
temperature was 35 °C. The molecular weight distribution of PDEGMA was135
calibrated with standard polystyrene samples.
2.3 Preparation of electrospinning solutions
PDEGMA and P(LLA-CL) were dissolved in HFIP under magnetic stirring for 10 h at
room temperature, resulting in clear and homogenous solutions. The component ratio140
of PDEGMA to P(LLA-CL) was 1:1, 1:2 or 1:3 (w/w), and the total concentration of
polymer was 9 % (w/v). Solutions containing P(LLA-CL) alone were also prepared as
controls. CIF was added into certain solutions at a drug to polymer ratio of 1:10
(w/w). Full details of all solutions are listed in Table 1.
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Table 1. Details of the spinning solutions used in this work. All solutions were
prepared in HFIP
Sample Solution contents
PDEGMA to
P(LLA-CL)
ratio (w/w)
Drug
concentration
(% w/v)
S1 PDEGMA/ P(LLA-CL) 1:1 ---
S2 PDEGMA/ P(LLA-CL) 1:2 ---
S3 PDEGMA/ P(LLA-CL) 1:3 ---
S4 P(LLA-CL) --- ---
S5
PDEGMA/ P(LLA-CL)
/CIF
1:1 0.9
S6
PDEGMA/ P(LLA-CL)
/CIF
1:2 0.9
S7
PDEGMA/ P(LLA-CL)
/CIF
1:3 0.9
S8 P(LLA-CL) /CIF --- 0.9
2.4 Preparation of fibers150
The solution required for electrospinning was placed into a 5 mL plastic syringe fitted
with a stainless steel needle (internal diameter 0.5 mm) and the syringe mounted on a
syringe pump (KDS100, Cole-Parmer, USA). The solution was expelled from the
syringe at a rate of 1.0 mL/h and a high voltage power supply (ZGF-2000, Shanghai
Sute Electrical Co. Ltd., China) used to apply a voltage of 16 kV between the needle155
and a grounded collector (a flat piece of aluminum foil of 10 x 10 cm). The distance
between the needle tip and the grounded collector was fixed at 15 cm. The relative
humidity was ca. 40 %, and the temperature 25 ºC. After electrospinning for 8 hours,
the products were stored in a vacuum oven at room temperature for 24 h to remove
7residual solvent.160
2.5 Fiber characterization
To observe the morphology of the fibers, samples were first gold sputter-coated for 60
s under argon to make them electrically conductive. Their morphological structure
was then investigated using a scanning electron microscope (SEM; JSM-5600 LV165
microscope, JEOL, Japan) at a voltage of 10 kV. The average fiber diameter for each
sample was calculated by the analysis of approximately 100 fibers in SEM images,
using the ImageJ software (National Institutes of Health, USA). X-ray diffraction
(XRD) patterns were obtained on a D/Max-BR diffractometer (Rigaku, Japan). The
instrument is supplied with Cu Kα radiation (40 kV / 30 mA), and patterns were 170 
collected over the 2θ range 5 – 60º. Fourier transformed infrared spectroscopy (FTIR) 
was undertaken using a Nicolet-Nexus 670 FTIR spectrometer (Nicolet Instrument
Corporation, USA) over the scanning range 500 – 4000 cm−1 at a resolution of 2 cm−1.
The water contact angle (CA) was determined on a contact angle analyzer (DSA 30,
Krüss GmbH, Hamburg, Germany) in air. A water droplet (ca. 1 µL) was placed onto175
the surface of the fibers and the CA recorded. The measurement temperature was
varied from 20 ºC to 45 ºC using a heating platform (XMTD-204, JTHF Company,
Jintan, China). Five measurements were recorded for each sample, and the results are
reported as mean ± S.D.
The water uptake capacity of the fibers and a commercial gauze (as control) was180
examined in PBS (pH 7.4; 37 ºC). Experiments were carried out in a humidified
incubator, and the samples weighed after 24 h. The water uptake capacity was
calculated as follows (Rath et al., 2016):
Water uptake capacity = (W-W0)/W0×100%
where W represents the weight of the sample after immersion in water and W0 the185
weight of the dry sample.
2.6 In vitro drug release
The loading of CIF in the nanofibers was first determined before the release
8experiment. 100 mg of fibers was dissolved in 10 mL of HFIP. The amount of190
dissolved CIF was then determined using a UV spectrophotometer (UV-1800, SHJH
Company, China) at 269 nm. The amount of CIF present in the nanofibers was
back-calculated against a predetermined calibration curve. The results are reported as
mean ± S.D. from three independent determinations.
Drug release experiments were then conducted at 37 ºC and 110 rpm in a thermostatic195
shaking incubator (Jintan Instrument Co. Ltd., China). 100 mg of each fiber mat was
separately immersed in 30 mL of a release medium (pH 7.4 PBS). At predetermined
time points, 1 mL of the test medium was withdrawn and an equal amount of fresh
preheated PBS was added. The amount of CIF released was determined using UV
spectroscopy. Experiments were carried out in triplicate and the results are reported as200
mean ± S.D.
2.7 Cell growth
Fibers were electrospun directly onto cover slips for these experiments 20 cover slips
were placed onto the collector plate and 5 mL of spinning solution was dispensed205
onto them. The slips were subsequently placed in the wells of 24-well plates, with
untreated cover slips used as a negative control. Before cell culture, the plates were
sterilized with alcohol steam for 24 h. 400 μL of dissociated L929 fibroblasts (1.0 × 
104 cells/mL, in DMEM supplemented with 10 % v/v FBS and 1 % (v/v)
penicillin–streptomycin) was added to each well, and the plate placed in an incubator210
(37 ºC, 5 % CO2). After 1, 3, or 5 days, the culture medium in each well was replaced
by 360 μL of fresh DMEM and 40 μL of an MTT solution (5 mg/mL thiazolyl blue in 
PBS). The plate was then incubated for 6 h, after which 400 μL DMSO was added to 
each well and the plates shaken for 30 min at room temperature. The purple solution
in each well was transferred to a 96-well plate and the number of cells assessed via215
the OD values at 570 nm. These were recorded using a microplate reader (Multiskan,
ThermoFisher, USA). Cell viability with a 0.9% CIF solution was also explored (see
Supporting Information for full details).
92.8 Cell detachment220
To test the detachment behavior of the thermosensitive nanofibers, L929 fibroblasts
were seeded onto cover slips covered with fibers in the 24-well plates as described
above, with fiber-free slips as a control. After incubation (37 ºC, 5 % CO2) for two
days, cell growth had exceeded 80% confluence. The samples were then transferred
to an incubator at 25 °C for 30 min. Subsequently, the contents of each well were225
aspirated and transferred to a fresh 6-well plate, which was returned to the 37 ºC
incubator to allow the detached cells to reattach to the new plates and resume growth
(Wang et al., 2006). The reattached cells were studied using an inverted microscope
(Olympus IX71, Japan). The number of cells remaining in each well of the original
plates was assessed using the MTT assay as detailed previously. For each fiber230
sample, cell detachment assays were performed three times, and the results are
expressed as mean ± S.D. Controls were established using cell-seeded slips incubated
at 37 ºC for the same period of time, but with no 25 ºC treatment. The detachment
ration was calculated as follows:
Detachment ratio = (A-B)/A×100%235
where A is the number of cells in the samples without the 25 ºC treatment, and B is
the number of cells remaining after this treatment.
2.9 Antibacterial activity
Antibacterial activities of the nanofibers were studied using disc diffusion method of240
the US Clinical and Laboratory Standards Institute (CLSI) (Unnithan et al., 2012). In
the assessment, 105 colony forming units (CFUs) of E. coli (Gram-negative; ATCC
25922) and S. aureus (Gram-positive; ATCC 27853) were selected as representative
microorganisms, and cultured on lauria broth (LB) and nutrient broth (NB) agar plates
respectively. The fiber samples were cut into circular discs 2 cm in diameter and245
sterilized by 75 % alcohol steam for 24 h. 100 μL of microorganism solution was 
cultured on an agar plate in a petri dish and then each of the samples was placed on
the surface of the agar plate. Next, all the dishes were incubated at 37 ºC for 72 h.
Inhibition zones were measured after incubation for 24 and 72 h. The antibacterial
10
property of a control CIF solution was also investigated using a shake flask method,250
as detailed in the Supporting Information.
2.10 In vivo experiments
All animal experiments were performed under certificate SYZK 2014-0022 issued by
the Shanghai Science and Technology Committee, in full accordance with their rules255
and regulations. Male SD (Sprague Dawley) rats from SLAC Laboratory Animal Inc.
(China) weighing from 220-250 g were used as animal models. The animals were
anesthetized with an intraperitoneal injection of pentobarbitone sodium (50 mg/kg)
and then a 3 cm × 3 cm (900 mm2) open excision type wound was created to the
depth of loose subcutaneous tissue on their upper backs. S6 or S8 fiber mats (see260
Table 1; 3 cm × 3 cm [900 mm2, 0.1g]) sterilized by alcohol steam for 24 h were used
to cover the skin wounds. An antiseptic gauze loaded with ampicillin (Shanghai
Yinjing Medical Supplies Company Ltd, China) was placed over each of the mats,
and the gauze edge was sutured to the skin around the wound area. This is in
accordance with previously reported protocols for such studies (Yang et al., 2011).265
Wounds i) sealed with ampicillin-loaded gauzes; ii) sealed with the same gauze
soaked with a 0.9 % w/v CIF solution; and, iii) sprinkled with a 0.9 % w/v CIF
solution (1.1 ml) were used as control groups . There were seven rats in each group.
2.11 Macroscopic observation of the wound healing process270
After recovery from anaesthesia, the rats were housed individually in disinfected
cages at a temperature of 25 ± 2 ºC. The dressings in all the groups were replaced
every three days. The rats in CIF solution group were treated with a 0.9 % CIF
solution every three days also. Before dressing replacement, the fibers and gauzes on
the wounds were treated by saline at 25 ºC. Replacement of the dressings every three275
days was undertaken to meet local clinical requirements in observing the healing
process and avoid infection. On day 0, 5, 14 and 21 post-operation, the appearance of
the wound was photographed. The area of unhealed wound was measured from the
image using the Photoshop software (Adobe, USA). The relative wound area was
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determined from the following equation:280
Relative wound area = At/A0×100%
where At and A0 are the wound areas on the specified day and operation day,
respectively.
2.12 Histological, immunohistochemical and toxicological examinations285
21 days after operation, three rats from each group were sacrificed using a large dose
of anesthetic. The wound sections were excised, collected and cut into small sections
(4 µm). The wound sections were fixed with 10 % formaldehyde, rinsed in water and
placed in a transparent tissue block of melted paraffin, ensuring that the samples were
completely immersed in the block. Sections were then block fixed on a slicer for290
hematoxylin-eosin (HE) staining. For staining, the sections were washed with
distilled water, stained with hematoxylin, rinsed under running tap water, and
differentiated with 0.3 % acid alcohol. They were next rinsed under running tap water
again, stained with eosin for 2 min, then dried, cleaned and mounted. HE-stained
sections were studied with a light microscope (Nikon Eclipse E400, Japan).295
In addition, some sections of tissue in the wound area from the same rats were
homogenized in RIPA lysis buffer. The total tissue protein was collected and
quantified by BCA protein kits. 60 μg of each sample was processed by SDS-PAGE 
electrophoresis on a 10 % SDS-PAGE gel at 100 V, followed by transfer to a PVDF
membrane (Millipore Corp., USA). After blocking with 5 % (w/v) skimmed milk for300
2 h at room temperature, the membrane was washed and incubated with primary
antibody at a dilution of 1:1000 for 30 min at room temperature, and then stored at 4
ºC overnight. The membranes were then washed three times with PBS containing
0.05 % Tween 20 and reacted with a secondary HRP-conjugated antibody for 1 h.
After being washed three times with PBS containing 0.05 % Tween 20 and reacted305
with the ECL luminescent reagent, the membranes were exposed and scanned. The
expression of CD34 and collagen type I in the regenerated tissues was detected with
β-actin as a protein loading control. 
To probe skin irritation, the area around the wound was studied for any kind of
12
oedema or erythema on the skin during the period of healing (Rath et al., 2016). To310
further examine the toxicity of the fibers, blood from rats in the fiber groups (S6 and
S8) was collected. This was assayed for a range of markers including the red blood
cell (RBC), white blood cell (WBC), and platelet counts. Hemoglobin, serum protein,
serum creatinine, hematocrit, serum glutathione, total cholesterol, uric acid, aspartate
amino transferase (AST) and glutamine transaminase (ALT) were also quantified315
using an automated Olympus AU5400 biochemistry analyzer (Olympus, Japan) to
Measurements obtained from normal rats without any wounds or treatment were used
as the control group.
3.Results and discussion.320
3.1. Synthesis and characterization of PDEGMA
The successful formation of PDEGMA was verified by 1H NMR (Figure 1). The
spectrum of DEGMA (Figure 1(a); D2O, 400 MHz) shows resonances as follows: δ 
(ppm): 6.00 (1H, CH2=C), 5.57 (1H, CH2=C), 4.18 (2H, -CH2-), 3.67 (2H, -CH2-),
3.57 (2H, -CH2-), 3.47 (2H, -CH2-), 3.22 (3H, -OCH3), 1.78 (3H, CH2=C-CH3). The325
spectrum of the polymer PDEGMA, shown in Figure 1(b), reveals the absence of
vinyl groups. The signals at δ of 6.0 and 5.57 of DEGMA have disappeared, 
demonstrating that PDEGMA was successfully obtained. The molecular weights (Mw
and Mn) and molecular weight distributions of PEDGMA determined by GPC were
35,573, 29,734, and 1.19, respectively.330
Figure 1
3.2 Fiber morphology
Scanning electron microscopy (SEM) images of the electrospun materials are shown335
in Figure 2, together with their diameter distributions. Fibers were successfully
prepared from all the solutions studied. Considering the fibers without CIF, the
average diameter can be seen to vary from 948 ± 132 nm (S4) to 476 ± 189 nm (S1)
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as increasing amounts of PDEGMA are incorporated into the nanofibers. This is
expected to be related to the rise in conductivity of the electrospinning solutions with340
increasing PDEGMA content (Yin et al., 2013). The diameter distributions of fibers
composed of P(LLA-CL) alone (S4) are also observed to be more uniform than those
of the blend systems.
The trends in fiber diameter and diameter distributions in the fibers loaded with
CIF are similar to those without drugs. However, the diameters of the CIF loaded345
fibers are rather narrower. For instance, the average diameter of S2 is 619 nm as
compared to 354 nm for S6. This may result from an increase in conductivity
following the addition of CIF; this is known to facilitate elongation of the polymer jet
and to generate narrower fibers (Su et al., 2009). There is also evidence for some
beading in the CIF loaded fibers depicted in Figure 2 (S5-S8), which might result350
from the addition of CIF causing increased viscosity (Pham et al., 2006).
Figure 2
3.3. X-ray diffraction355
X-ray diffraction (XRD) patterns are presented in Figure 3. Ciprofloxacin (CIF)
shows a number of well-defined Bragg reflections in its diffraction pattern,
demonstrating its crystalline nature. However, all the fibers loaded with CIF display
only two broad diffuse features centered at around 7° and 17° 2θ, indicating they are 
amorphous materials. These results demonstrate that CIF was converted into the360
amorphous physical form by the electrospinning process.
Figure 3
3.4 Thermoresponsive behavior365
The thermosensitive behavior of the nanofibers loaded with CIF was studied, and the
results are depicted in Figure 4(a). The neat P(LLA-CL) fibers loaded with CIF are
hydrophobic regardless of the temperature, with perhaps very slightly lower contact
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angles at lower temperatures. In contrast, as the temperature is reduced from 45 ºC to
20 ºC, the surfaces of the PDEGMA-containing fibers change significantly, although370
to different extents. The S5 nanofibers, which contain the largest proportion of
PDEGMA (1:1 PDEGMA: P(LLA-CL) w/w), have a contact angle of around 90° at
45 ºC. Below 30 ºC, this value decreases dramatically and reaches 0º at 20 ºC. In
comparison, the contact angle of the sample with the lowest proportion of PDEGMA
(S7, 1:3) starts with a contact angle of more than 120 º at 45 ºC, which declines to375
about 90 º at 20 ºC. The S6 fibers (1:2) have the most marked thermosensitive
behavior, with a decline in contact angles from hydrophobic (ca. 120º) at 45 ºC to
hydrophilic (15º) at 20 ºC.
The contact angles of all the fibers containing PDEGMA thus exhibit a dramatic
change near 30 ºC, the LCST of PDEGMA. PDEGMA will be soluble in water below380
the LCST but precipitate at temperatures above it. Below the LCST, the balance
between favorable polymer-water interactions and unfavorable hydrophobic
interactions lies in favor of the former, allowing solubilization. Above the LCST, this
balance is disrupted and polymer–polymer interactions are thermodynamically
favored over polymer-water interactions (Lutz et al., 2007; Maeda et al., 2007; Lutz,385
2008). As a result, the polymers become hydrophobic above the LCST, explaining the
higher contact angles observed at elevated temperatures.
Figure 4.
390
3.5 IR spectroscopy
IR spectra are shown in Figure 4(b). PDEGMA exhibits distinctive peaks at 2928 and
2881 cm-1, which represent the C-H stretching vibrations of CH3 and CH2,
respectively. The strong peak at 1728 cm-1 results from the stretching vibration of
C=O. Another characteristic peak at 1111 cm-1 corresponds to C-O stretching. The395
spectrum of (PLL-CL) fibers (S4) shows features at 2948 and 1757 cm-1, arising from
the stretching of -CH3 and C=O, respectively. Two peaks at 1183 and 1093 cm-1 are
caused by the stretching of C-O-C. The IR spectrum for CIF shows distinct peaks at
15
1589, 1544 and 1500 cm-1 from stretching vibrations of the benzene ring. The peak at
3046 cm-1 corresponds to O-H stretching. C=O stretching is visible at 1616 cm-1.400
Considering the spectra of S2 and S6, both show two adjacent peaks at 1757 and 1729
cm-1 from the stretching vibrations of C=O, which can be explained by the presence
of PEDGMA and P(LLA-CL). The IR spectra of the other fibers similarly contain the
major features from their polymer constituents. The drug-loaded S6 material has an
additional feature at 1619 cm-1. This corresponds to CIF, demonstrating that CIF was405
incorporated into the S6 nanofibers. Similarly, the other drug-loaded systems, S5, S7
and S8, also show additional peaks at 1619 cm-1, confirming the presence of CIF.
3.6 In vitro release behavior
The loadings of CIF in the fibers (S5, S6, S7 and S8) were determined prior to the410
investigation of their release behavior (Table 2). It was determined in all cases that
more than 85% of the theoretical loading of CIF was present in the fibers, which
demonstrates that most of the drug could be incorporated into the fibers successfully.
It is thought that the remaining CIF may have crystallized out of solution onto the
needle and/or the walls of the syringe, owing to the very low solubility of this drug.415
The CIF release profiles from the fibers are depicted in Figure 4(c). The cumulative
release percentage is expressed as a percentage of the measured loading. CIF is freed
from the S8 ((P(LLA-CL) and CIF) fibers with an initial burst release of 40 % during
the first 10 h, followed by further gradual release over more than 200 h. After
immersion for 220 h, the release of CIF reached a plateau at ca. 79 %. With regard to420
the composite nanofibers (S5, S6 and S7), all of them also exhibit a burst release of
approximately 45 % in the first 10 h, after which gradual release occurs over about
170 hours. With increasing amounts of PDEGMA in the fibers, there appears to be a
very slight increase in the CIF release rate. The cumulative CIF release percentages of
S5, S6 and S7 reach around 85 %, 83 % and 81 %, respectively, higher than the value425
for S8, the sample without PDEGMA.
The initial bursts of release observed in all the samples are the result of the presence
of some CIF at the surface of the fibers. It has been shown conclusively in the
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literature that drug release from polymers in vitro is caused by diffusion, polymer
erosion or a combination of both, and that release from a hydrophilic carrier tends to430
be faster than that from a hydrophobic material (Lin et al., 2012; Dong et al., 2008).
The wettability of S5 is the highest of the four samples at 37 ºC, followed by S6, S7
and S8. This mirrors the order of release rates, where we see S5 > S6 > S7 > S8. At
the end of the release period, it can be seen that over 15 % of the incorporated CIF
was not freed into the release medium. It is believed that some CIF is encapsulated435
deep inside the fibers, especially with S8, which has the most hydrophobic properties.
These results thus demonstrate that the PDEGMA/ P(LLA-CL) blend fibers can
deliver sustained release of CIF over more than 7 days. Given this promising data, the
fibers could extend the usage period and reduce the replacement frequency of wound
dressing materials.440
Table 2. The loadings of CIF in the fibers, expressed as a percentage of the theoretical
loading. Data are reported as mean ± S.D. from three independent experiments.
Sample
S5
(1:1+CIF)
S6
(1:2+CIF)
S7
(1:3+CIF)
S8
(P(LLA-CL)+C
IF)
CIF loading
(%)
86.6 ± 5.7 87.3 ± 5.1 85.6 ± 6.9 86.9 ± 5.5
445
3.7 Cell growth and detachment
It is reported that fibroblast cells are essential for wound healing, so L929 cells were
chosen to test the cytocompatibility of the fibers (Cook et al., 2000). As a control, the
viability cell of a 0.9% CIF solution (providing the same drug concentration as the450
fibers) was also explored. The results for this control experiment are shown in the
Supporting Information (Figure S1). It can be seen that the number of cells increases
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continuously from 1 to 5 days, and at day 1 and 3 the untreated and CIF-treated
results are indistinguishable. After 5 days, there are somewhat fewer cells present
after CIF treatment. Overall, these data indicate that CIF has generally good455
cytocompatibility with this cell line.
As is depicted in Figure 5(a), the numbers of cells incubated on the fibers also
increases from day 1 to day 5 under all conditions tested. The cell viabilities observed
with all the fibers are similar, and they are significantly greater than those of the
negative control (cover slips) especially on the 1st and 5th day (p < 0.05). The amount460
of PDEGMA in the fibers has no major influence on their cytocompatibility.
The percentages of cells remaining attached to the cover slips after a treatment at
25 °C are shown in Figure 5(b). It is clear that with blank coverslips and with
coverslips coated in S8 (PLLA/CIF only), virtually 100 % of the cells present
remained attached after the 25 ºC treatment. In contrast, with the465
PDEGMA-containing systems some of the cells can be detached by exposure to a
temperature below the LCST. S5, which has the highest PDEGMA content, has the
lowest percentage of cells remaining attached, at only 35.2 %. Significantly more
cells remained attached to the S7 fibers (76.44 %; p < 0.05). During the standard
incubation at 37 °C, above the LCST of PDEGMA, polymer-polymer interactions470
dominate, creating a hydrophobic surface on the blend fibers. P(LLA-CL) is also a
hydrophobic polymer. Hence, adsorption of extracellular matrix (ECM) proteins onto
the surface of the fiber mats is possible, which promotes cell adhesion (Brun-Graeppi
et al., 2010; Cole et al., 2009). The treatment at 25 °C is below the LCST of
PDEGMA, and thus polymer-water interactions lead to a hydrophilic surface on the475
blend fibers. It is more difficult for proteins to adsorb onto such a hydrophilic surface
(Chen et al., 2005; Okano et al., 1995), which causes the cells to become detached.
The greater the amount of PDEGMA present in the fibers the more significant this
effect becomes, and thus the larger the number of cells which are detached.
When the detached cells are transferred to a fresh 6-well plate and incubated at 37 °C,480
they can reattach themselves to the plate surface and grow normally (Figure 5(c)).
This indicates that the detached cells have good viability, with no evidence of
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accelerated cell death observed after the detachment process. The composite
PDEGMA/P(LLA-CL) fibers could thus be used as thermosensitive wound dressings:
application of a reduced-temperature treatment inhibits the adhesion of cells and485
could be implemented to reduce secondary injuries.
Figure 5
3.8 Antibacterial activity490
CIF is a fluoroquinolone, and is one of the most widely used antibiotics because of its
low minimal inhibitory concentration for bacteria. The frequency of spontaneous
resistance to CIF is also very low (Yu et al., 2006; Dillen et al., 2004). Control
experiments were first performed to verify the antibacterial activity of CIF against E.
coli and S. Aureus (see Figure S2): as is widely reported, this drug was extremely495
effective in preventing bacterial growth, with inhibition after 3 days calculated to be
87.5 ± 6.2% and 84.6 ± 2.8% against E. coli and S. Aureus respectively.
The results of antibacterial activity assays with the fibers are summarized in Table 3,
with exemplar images given for S2 (with a PDEGMA to P(LLA-CL) ratio of 1:2) and
S6 (analogous to S2, but CIF-loaded) in Figure 6. A clear inhibition zone within and500
around the drug loaded S6 fibers can be seen after an overnight incubation of the agar
plate at 37°C, for both the Gram-positive and Gram-negative bacteria. However, these
inhibition zones do not appear with the fibers without CIF (S2). The inhibition zones
for E. coli and S. aureus after 24 h are 5.35 ± 0.51 cm and 5.21 ± 0.44 cm,
respectively. The complete date in Table 3 clearly demonstrate that the inhibition505
zones of all the fibers loaded with CIF (S5-S8) are similar after 24 h, indicating
comparable antibacterial effects, and inhibition zones cannot be seen in the groups
without CIF (S1-S4).
After incubation for 72 hours, the inhibition zones are slightly larger than those
observed after 24 h, indicating the antibacterial activity of the fibers persists for at510
least three days. This can be attributed to the drug release behavior of the fibers: as
19
discussed above, CIF is released from the fibers gradually over more than 150 hours.
It is clear that, given the lack of inhibitory zones in the CIF-free fibers, that the
antibacterial activity of the drug-loaded systems is caused by CIF. The ability of
wound dressings to avoid infection by exogenous organisms is regarded as a515
requirement for an efficacious product, and hence the PDEGMA/P(LLA-CL)
nanofibers loaded with CIF can potentially be applied as antibacterial wound dressing
materials.
520
Table 3. Inhibition zone diameters for the fibers. Data are reported as mean ±
S.D. from 5 independent experiments.
Sample Inhibition zones against
E.coli (cm)
Inhibition zones against S.
aureus (cm)
24 hours 72 hours 24 hours 72 hours
S1 --- --- --- ---
S2 --- --- --- ---
S3 --- --- --- ---
S4 --- --- --- ---
S5 5.52 ± 0.63 5.64 ± 0.43 5.24 ± 0.38 5.32 ± 0.37
S6 5.35 ± 0.51 5.45 ± 0.81 5.21 ± 0.44 5.62 ± 0.53
S7 5.39 ± 0.58 5.57 ± 0.25 5.45 ± 0.82 5.55 ± 0.18
S8 5.28 ± 0.12 5.40 ± 0.26 5.52 ± 0.66 5.61 ± 0.83
Figure 6525
3.9 Fiber degradation and water uptake in vitro
The degradation of the fibers was explored in vitro, in order to validate that they
would persist in physiological media for long enough to effect wound healing. The
results are given in Figure S3. The weight loss after 6 weeks is found to be less than
20
10%. Further, the pH of the buffer used for degradation remained largely constant530
over this period, declining only from ca. 7.25 to 6.75. This indicates that only small
amounts of lactic acid are being feed from the fibers, and thus that local inflammation
from this effect is likely to be minimal. The fiber mats are found to be able to uptake
large amounts of water (between 80 and 170 % by weight; Table S1). This is
somewhat less than the gauze (approx.. 180 %), but nevertheless demonstrates the535
porosity of the fibers and their abilities to absorb wound extrudates.
3.10 Macroscopic observation of the wound healing process
The ability of the fibers to aid wound healing in vivo was explored with S6 and S8,
with a commercial gauze (Shanghai Yinjing Meidical Supplies Company Ltd), the540
same gauze immersed in a 0.9% w/v CIF solution and a 0.9% w/v CIF solution used
as control groups. Figure 7 shows representative images of the wound healing
process. The rats awoke around 3 hours after the operation, and appeared healthy. In
the groups treated with gauze, gauze soaked with CIF and CIF solution (Figure 7(a),
(b) and (c)), thicker scabs or bleeding can be seen, resulting from local inflammation.545
These groups additionally demonstrate slower wound healing than those treated with
S6 and S8.
Among the 5 groups, the S6 dressings were easiest to remove from the wounds after
treatment with cold saline. Moreover, S6 shows the best healing performance. After 5
days, the wound treated with S6 was completely covered by a scab and there were no550
signs of infection. After 14 days, the area of the wound was much reduced. At the end
of the period (21 days), the wound was largely scab-free and mostly filled with
regenerated skin and hairs. This process is clearly occurring more rapidly with S6,
with S8 somewhat less effective and the wounds covered with gauze only healing
noticeably more slowly.555
The relative wound areas of the various groups after operation are given in Figure 8.
The results are in accord with those in Figure 7. After 5 days, the wound areas are
almost the same as immediately post-operation with all groups. Subsequently the
wound areas decline rapidly. After 21 days, S6 shows the lowest area, at 5.7 ± 0.8 %
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of the original area, with S8 (14.3 ± 1.6 %) performing significantly less well (p <560
0.05). Because of the presence of PDEGMA in S6, these fibers could be removed
from the wounds more easily than S8. As a result, the induction of secondary injuries
during the changing of dressings is reduced and the wound healing is faster.
The wound areas of the groups treated with gauze, gauze soaked with CIF solution,
and CIF solution remain high even after 21 days, at 30.8 ± 2.2 %, 26.5 ± 1.9 % and565
28.3 ±1.7%, respectively. The presence of CIF in the gauze clearly helped to speed up
the wound healing process, and the application of the gauze covered and protected the
wounds. However, healing in these groups is significantly slower than in those treated
with S6 and S8 (p < 0.05).
The degradation of the fiber mats was also studied in vivo (see Figures S4 and S5).570
The S6 and S6 systems undergo less than 10 % mass loss over 4 weeks of use as a
wound dressing (Figure S4). SEM images (Figure S5) show that there are no major
changes in morphology after the fibers are placed on and removed from skin, be this
healthy skin or a wound. Only a small amount of swelling can be observed.
It has been reported that there are a number of advantages in using electrospun575
nanofibers as wound dressings, resulting from their high surface area-to-volume ratio,
hemostasis, semi-permeability, functional ability, etc (Zahedi et al., 2010; Zou et al.,
2011). In particular, the thermoresponsive behavior of S6 is thought to facilitate cell
detachment, reducing secondary injuries and hence leading to improved healing
performance over S8. The water uptake of S6 is somewhat greater than that of S8 (see580
Table S1), which may also contribute to its improved performance. However, both
sets of fibers absorb less water than the commercial gauze, and the latter performs
worse in healing. Thus, water uptake is not thought to be the key factor in
determining the efficacy of healing. Moreover the sustained release of CIF from the
fibers prevents bacterial contamination and thus also contributes to the faster healing585
of wounds. Therefore, we can be confident that the PDEGMA/P(LLA-CL) nanofibers
loaded with CIF are promising materials for wound healing in rats in vivo.
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Figure 7
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Figure 8
3.11 Toxicological evaluation, histological examinations and protein expression
None of the nanofiber dressings applied showed any hypersensitivity reactions on the
skin. There was no sign of erythema, eschar or edema, which indicates the safety of595
the fiber as wound dressings. Toxicological results obtained on blood samples are
detailed in Table S2. In all cases, the values obtained for animals treated with the fiber
wound dressings are almost identical to an untreated control. These findings make it
clear that the fibers are safe to use as wound dressings.
Histological data are presented in Figure 9. New epidermis, marked by rectangles,600
could be observed at the edge of the wound in all groups. In the gauze group (Figure
9(a)), the epidermis is very thin and irregular, and inflammation (black arrows) can be
seen in the sections. The groups treated with gauze soaked in 0.9% CIF solution and
CIF solution (Figure 9(b) and (c)), have wounds which are completely epithelized,
but the epidermis is not continuous and is irregular in its thickness. In contrast, the605
regeneration of the epidermis in the fiber groups (Figure 9(d) and (e)) is much more
complete. It can be seen that the basal cells (white arrows) are uniform in shape and
are arranged close together. The continuity and regularity of the epidermis are closer
to the normal skin (Figure 9(f)) than any of the other treatment groups. Compared to
S8, the thickness of the epidermis in S6 is more uniform. Further, the horny layers610
(marked by a circle in Figure 9) in the S6 group are dense and more interconnected.
Again, these are closed to the normal skin than is seen with the other groups, although
it should be noted that some fragments were induced while preparing the histological
sections. The horny layers in S8 are not at all obvious, which may result from the
secondary injuries arising while the dressings were replaced. These results agree fully615
with the outcomes of the macroscopic observations discussed above, demonstrating
the enhanced healing performance of S6 over the other groups.
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Figure 9
620
To probe the mechanism underlying the acceleration of wound healing by the fibers,
the expression of CD34 and collagen type I in the regenerated tissues of all the in vivo
groups were evaluated by Western blotting assays, using β-actin as protein loading 
control. After 5 days the expression of CD34, a marker of vascular endothelial cells, is
low in the groups treated with gauze (Figure 10(a)), gauze soaked in CIF (Figure625
10(b)) and CIF solution (Figure 10(c)). In contrast, at this time point CD34 is highly
expressed in rats treated with S8 (Figure 10(d)) and S6 (Figure 10(e)). After 14 days,
CD34 is highly expressed in the groups treated with gauze with and without CIF or
with the CIF solution, while the amount present in the fiber-treated wounds has
declined. 21 days post-operation, the expression of CD34 had declined in all treatment630
groups. CD34 expression in normal skin remains low during the entire period, as it is
not expressed in skin without wounds.
The expression of CD34 can be related both to the release of CIF and the other
wound-healing attributes of the fibers. The release of CIF from the nanofibers is
sustained, which can prevent the infection of wounds in the early stage of healing. As635
a result, a large number of vascular endothelial cells proliferate and migrate into the
wound region to participate in the regeneration of blood capillaries and promote
healing (Wilgus, 2008). The ability of the fibers to absorb extrudates and (in the case
of S6) encourage cell detachment is synergistic with this and results in early wound
healing and upregulation of CD34. In contrast, while the CIF can still exert its640
antibacterial properties in the control groups, these lack the other advantageous
properties of the fibers, and hence CD34 levels peak later.
Collagen is the main constituent of the extracellular matrix secreted by fibroblasts,
and collagen type I is a major component of regenerated skin (Yang et al., 2011).
Hence, high levels of collagen type I expression can be seen in the normal skin at each645
time point (see Figure 10). During the wound healing process, collagen type I
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expression continuously increased in all the experimental groups. Rats treated with S6
(Figure 10(e)) exhibit the highest amount of at each time point, followed by S8. By
the 21st day, the collagen band is as intense from the S6 group as in normal skin,
showing that healing is almost complete. These results support the macroscopic650
wound appearance study and the histological staining data. Therefore, all the results
of the in vivo experiments are in agreement and demonstrate that the S6 fibers
exhibited better healing performance than all the other groups.
655
Figure 10
4. Conclusions
In this study, the thermosensitive polymer PDEGMA (poly(di(ethylene glycol) methyl660
ether methacrylate) was first synthesized and characterized. Composite nanofibers of
PDEGMA and P(LLA-CL) (poly(l-lactic acid-co-ɛ-caprolactone)) were successfully 
prepared by electrospinning, and analogous ciprofloxacin (CIF)-loaded fibers were
also generated. Electron microscopy showed that smooth fibers were produced,
although a small number of beads can be seen in the ciprofloxacin-loaded fibers. The665
fiber diameters decrease with increases in the proportions of PDEGMA and CIF in the
formulations. X-ray diffraction showed that CIF was present in the amorphous
physical form after electrospinning. The water contact angle of the composite
nanofibers increases abruptly when the temperature is increased through the lower
critical solution temperature of 32 ºC. The fibers thus undergo a rapid670
hydrophilic/hydrophobic transition at this point. Sustained release of CIF from the
drug-loaded fibers was observed to proceed over more than 160 hours, and the fibers
were able to promote the adhesion and proliferation of L929 fibroblasts. By reducing
the culture temperature, cells could be detached from the PDEGMA-containing fibers.
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The composite fibers loaded with CIF also inhibited the growth of E. coli and S.675
aureus. In vivo tests demonstrated that PDEGMA/PLLA fibers loaded with CIF had
better wound healing performance compared with commercial gauze or PLLA/CIF
fibers. Our findings therefore show that PDEGMA / P(LLA-CL) / ciprofloxacin fibers
can act as potent wound dressing materials.
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Figures
Figure 1. 1H NMR spectra of (a) DEGMA and (b) PDEGMA
835
32
Figure 2. SEM images and diameter distributions of the fibers prepared in this work.
33
Figure 3. XRD patterns of CIF and the CIF loaded nanofibers
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(a)
(b)
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(c)
Figure 4. a) The temperature dependence of the fibers’ water contact angles; b) FTIR
spectra of PDEGMA, CIF and selected fibers (S2, S4 and S6); and, c) The in vitro
release profiles of CIF from the drug-loaded fibers. Data are reported as mean ± S.D.
from three independent experiments.850
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Figure 5. a) Cell viability after exposure to the electrospun fibers for 1, 3, or 5 days; b)
The percentage of L929 fibroblasts remaining attached to the fibers after treatment at
25 ºC; and, c) A micrograph of L929 fibroblasts detached from the S6 fibers and855
cultured in a fresh plate at 37 °C (magnification: ×100). Data in Figure 3 (a) and (b)
are from three independent experiments, and are reported as mean ± S.D. * indicates a
signiﬁcant difference between two groups (p<0.05) and # indicates a signiﬁcant 
difference from all other groups (p < 0.05).
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Figure 6. Bactericidal activity of selected fiber samples. Representative photographs
of a) S2 against E. coli; b) S6 against E.coli; c) S2 against S. aureus; and, d) S6
against S. aureus, taken from 5 replicate experiments.
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Figure 7. Representative images of skin wounds after treatment with selected fibers
for 0, 5, 14 and 21 days post-operation. The wounds were treated with (a) a
commercial gauze alone; (b) the same type of gauze soaked with a 0.9 % CIF solution;
(c) CIF solution; (d) S8; and, (e) S6.870
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Figure 8. Relative wound areas 0, 5, 14 and 21 days post-operation. Results are from
7 rats, and expressed as mean ± S.D. The wounds were treated with (a) a commercial
gauze alone; (b) the same type of gauze soaked with a 0.9 % CIF solution; (c) CIF875
solution; (d) S8; and, (e) S6. * indicates a signiﬁcant difference between two groups 
(p<0.05) and # a signiﬁcant difference to all other groups at the same timepoint (p < 
0.05).
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Figure 9. HE staining for the epithelialization of skin wounds treated for 21 days with
(a) a commercial gauze alone; (b) the same type of gauze soaked with a 0.9 % CIF
solution; (c) CIF solution; (d) S8; and, (e) S6, and are presented together with data for
(f) normal skin without any wounds or treatment. These are representative images
from three rats of each group, and scale bars represent 40 mm. Images on the right885
have larger magnificent than those on the left.
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Figure 10. Western blotting results for CD34 and collagen expression in skin wounds
treated with (a) gauze; (b) gauze soaked with a 0.9 % CIF solution; (c) CIF solution;
(d) S8; (e) S6; and, (f) normal skin after 5, 14 and 21 days. Total proteins were890
prepared from skin wounds, and β-actin expression was used as the protein loading 
control.
